Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
Aug 26, 16:00
Kezar Life Sciences EPS Diluted (TTM) : -6.176 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -6.176 |
| December 31, 2025 | -7.659 |
| September 30, 2025 | -8.443 |
| June 30, 2025 | -9.694 |
| March 31, 2025 | -10.78 |
| December 31, 2024 | -11.49 |
| September 30, 2024 | -13.15 |
| June 30, 2024 | -13.55 |
| March 31, 2024 | -13.94 |
| December 31, 2023 | -14.04 |
| September 30, 2023 | -12.12 |
| June 30, 2023 | -11.41 |
| March 31, 2023 | -10.58 |
| December 31, 2022 | -10.15 |
| September 30, 2022 | -10.17 |
| June 30, 2022 | -10.48 |
| March 31, 2022 | -10.46 |
| December 31, 2021 | -10.36 |
| September 30, 2021 | -10.01 |
| Date | Value |
|---|---|
| June 30, 2021 | -9.485 |
| March 31, 2021 | -9.200 |
| December 31, 2020 | -9.701 |
| September 30, 2020 | -12.53 |
| June 30, 2020 | -15.06 |
| March 31, 2020 | -17.42 |
| December 31, 2019 | -18.38 |
| September 30, 2019 | -16.42 |
| June 30, 2019 | -14.61 |
| March 31, 2019 | -43.14 |
| December 31, 2018 | -41.72 |
| September 30, 2018 | -39.89 |
| June 30, 2018 | -37.99 |
| March 31, 2018 | -5.87 |
| December 31, 2017 | -4.460 |
| September 30, 2017 | -3.256 |
| June 30, 2017 | -2.167 |
| March 31, 2017 | -1.183 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| NovelStem International Corp. | -0.0064 |
| Brainstorm Cell Therapeutics, Inc. | -0.9541 |
| Summit Therapeutics, Inc. | -1.119 |
| Protara Therapeutics, Inc. | -1.354 |
| Clene, Inc. | -3.512 |